Optimize Medical Summarization: Build vs. Buy

When your organization identifies the need for new software capabilities, the conversation often starts with a familiar question: should we build internally or invest in a proven third-party solution?

The answer carries long-term implications. Each choice influences not only your technology stack but also your operating model, data strategy, and the productivity of your people. That’s why selecting the right path demands a structured, objective evaluation — one grounded in business outcomes, scalability, and total cost of ownership.

A 2025 report published by MIT, reports that purchasing AI tools from specialized vendors and building partnerships succeed about 67% of the time, while internal builds succeed only one-third as often.

This whitepaper outlines a decision framework to help technology and business leaders assess their options confidently. It highlights how to balance control with agility and design an implementation approach that positions your organization to fully leverage Medical Summarization as a strategic capability.